withanolides and Liver-Diseases

withanolides has been researched along with Liver-Diseases* in 2 studies

Reviews

1 review(s) available for withanolides and Liver-Diseases

ArticleYear
Withaferin A in the Treatment of Liver Diseases: Progress and Pharmacokinetic Insights.
    Drug metabolism and disposition: the biological fate of chemicals, 2022, Volume: 50, Issue:5

    Withaferin A (WA) is a natural steroidal compound used in Ayurvedic medicine in India and elsewhere. Although WA was used as an anticancer reagent for decades, its role in the treatment of liver diseases has only recently been experimentally explored. Here, the effects of WA in the treatment of liver injury, systematic inflammation, and liver cancer are reviewed, and the toxicity and metabolism of WA as well as pharmacological potentials of other extracts from

    Topics: Humans; Liver Diseases; Medicine, Ayurvedic; Withania; Withanolides

2022

Other Studies

1 other study(ies) available for withanolides and Liver-Diseases

ArticleYear
Comparison of the protective effect of Withaferin-'A' and hydrocortisone against CCL4 induced hepatotoxicity in rats.
    Indian journal of physiology and pharmacology, 1992, Volume: 36, Issue:2

    Protective effect of Withaferin-'A' against CCl4 induced hepatotoxicity has been assessed and the compound at 10 mg/kg dose was found to possess significant protective effect. A comparison of this protective effect with that of hydrocortisone showed it to be as effective as hydrocortisone dose per dose.

    Topics: Alkaline Phosphatase; Animals; Blood Proteins; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Drug Interactions; Ergosterol; Female; Hydrocortisone; Liver; Liver Diseases; Male; Rats; Withanolides

1992